HEPION PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
HEPION PHARMACEUTICALS, INC. (HEPA) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.10% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-03-12
- HEPION PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.10%, a 120.00% decline from fiscal 2023.
- HEPION PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was 0.50%.
- HEPION PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -4.60%.
- HEPION PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was -1.10%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -0.10% 10-K · filed 2026-03-12 | 0.00% 10-K · filed 2025-04-08 |
| 2023-12-31 | 0.50% 10-K · filed 2025-04-08 | |
| 2022-12-31 | -4.60% 10-K · filed 2024-04-16 | |
| 2021-12-31 | -1.10% 10-K · filed 2023-04-10 | |
| 2020-12-31 | -1.70% 10-K · filed 2022-04-08 | |
| 2019-12-31 | -4.70% 10-K · filed 2021-03-31 | |
| 2018-12-31 | -1.60% 10-K · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |